DDIT3/ CHOP levels showed an increasing trend, although the difference between the groups did not reach statistical significance.
← all excerpts
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma.
1
—
—
DDIT3/ CHOP levels showed an increasing trend, although the difference between the groups did not reach statistical significance.